UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Makragiannis, G; Vahdani, K; Carreño, E; Lee, RWJ; Dick, AD; Ross, AH; (2018) Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis. International Ophthalmology , 38 (2) pp. 781-785. 10.1007/s10792-017-0502-x. Green open access

[thumbnail of Makragiannis_Bevacizumab_treatment_choroidal_AAM.pdf]
Preview
Text
Makragiannis_Bevacizumab_treatment_choroidal_AAM.pdf - Accepted Version

Download (212kB) | Preview

Abstract

PURPOSE: To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab. METHODS: Case report. RESULTS: A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT. CONCLUSIONS: Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.

Type: Article
Title: Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s10792-017-0502-x
Publisher version: http://doi.org/10.1007/s10792-017-0502-x
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Candida, Chorioretinitis, Choroidal neovascular membrane, Bevacizumab
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery.ucl.ac.uk/id/eprint/1547439
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item